Novo Nordisk is continuing its citizen petition crusade at the FDA, this time aiming to stop the compounding of Victoza, its blockbuster GLP-1. The push
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Neumora’s share price plummeted after the company shared news on a Phase III trial failure for its lead candidate. Credit: Ground Picture via Shutterstock Neumora
Leading strategic intelligence solutions for the pharmaceutical industry: Introduction In the world of business, across many sectors, the need for a strategic intelligence solution has
The holidays came with a side of flu for many Americans, with 40 states reporting high or very high levels of illness last week, according
“CBD is known for its soothing and anti-inflammatory properties, which makes it your period’s perfect partner in crime.” “… a CBD coating for the days
In a new report emphasizing the link between alcohol and cancer, U.S. Surgeon General Vivek Murthy, MD, MBA, calls for warnings on package labels similar
Liver cells damaged by diet-driven metabolic dysfunction are like a “ticking time bomb” in the evolution of liver cancer, according to a study in Nature.
People who died with sporadic Creutzfeldt-Jakob disease were more likely to have been prescribed antidepressants before neurologic symptoms started, a retrospective study in Austria showed.